Digital Diagnostics Inc.

In April 2018, Digital Diagnostics(formerly known as IDx) became the first company to ever receive FDA clearance for an AI diagnostic platform that makes a diagnosis without physician input at the point-of-care. This achievement did not happen overnight – it was the culmination of decades of research by founder Dr. Michael Abramoff on automated image analysis, combined with decades of research on how clinicians diagnose disease. Tomorrow, Digital Diagnostics is launching additional AI platforms for the detection of a wide range of disease states beyond the eye. Digital Diagnostics is a leading AI diagnostic healthcare technology company on a mission to transform the quality, accessibility, and affordability of healthcare world-wide.